secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0001493152-23-007473
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVMED's Lucid Diagnostics raises $13.625M via Series A Preferred private placement
--------------------------------------------------------------------------------

- Issued 13,625 shares of Series A Convertible Preferred at $1,000/share; gross proceeds $13.625M.
- Closing occurred on March 7, 2023; private placement with accredited investors.
- Certificate of Designation filed with Delaware establishing Series A Preferred terms.
- Further details incorporated by reference to Lucid Diagnostics' Form 8-K filed March 13, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315223007473/0001493152-23-007473-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315223007473/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-007473

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer